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Original Article
Inflammatory pathways are central
to posterior cerebrovascular artery
remodelling prior to the onset of
congenital hypertension
Dawid Walas1 , Karol Nowicki-Osuch2, Dominic Alibhai3,
Eva von Linstow Roloff1, Jane Coghill4, Christy Waterfall4
and Julian FR Paton1,5
Abstract
Cerebral artery hypoperfusion may provide the basis for linking ischemic stroke with hypertension. Brain hypoperfusion
may induce hypertension that may serve as an auto-protective mechanism to prevent ischemic stroke. We hypothesised
that hypertension is caused by remodelling of the cerebral arteries, which is triggered by inflammation. We used a
congenital rat model of hypertension and examined age-related changes in gene expression of the cerebral arteries using
RNA sequencing. Prior to hypertension, we found changes in signalling pathways associated with the immune system and
fibrosis. Validation studies using second harmonics generation microscopy revealed upregulation of collagen type I and IV
in both tunica externa and media. These changes in the extracellular matrix of cerebral arteries pre-empted hypertension
accounting for their increased stiffness and resistance, both potentially conducive to stroke. These data indicate that
inflammatory driven cerebral artery remodelling occurs prior to the onset of hypertension and may be a trigger elevating
systemic blood pressure in genetically programmed hypertension.
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Introduction
Hypertension remains the biggest ‘silent killer’ in
the world1 with 29% of people suﬀering from it glo-
bally.2 If left untreated, hypertension presents a
major risk of stroke, cardiac and renal disease.1
In around 95% of cases, the cause of hypertension
is unknown and dubbed ‘essential’.3 The multifactor-
ial nature of this syndrome has made it diﬃcult
to pinpoint the exact cause(s). Moreover, around
12–15% of hypertensive patients may be resistant to
current therapies.4 Thus, there is a pressing need for
unearthing root causes and developing new appropriate
therapies.
Many patients with hypertension also have activa-
tion of the sympathetic nervous system that may occur
prior to the onset of hypertension and therefore
contribute to both the development and maintenance
of high blood pressure (reviewed by Fisher and
Paton5). The big and unresolved question is what trig-
gers the increase in sympathetic nerve activity? In the
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early 1960s, Dickinson found a strong correlation
between vertebral artery resistance and the ante-
mortem blood pressure in cadavers; thus he conﬁrmed
with X-ray images showing that the vertebral arteries
of hypertensive subjects were narrowed compared to
their normotensive counterparts.6–9 However, the
causality of this relationship could not be determined.
The vertebral arteries provide blood to the basilar
artery that perfuses the brainstem, the major region
controlling sympathetic vasomotor activity that regu-
lates blood pressure. We conﬁrmed the correlation of
heightened basilar artery resistance and narrowed ver-
tebral and basilar arteries in the spontaneously hyper-
tensive rat (SHR) when compared to its parental
strain – the Wistar Kyoto rat (WKY).10 Intriguingly,
the higher resistance and vertebrobasilar artery nar-
rowing (‘remodelling’) were found in juvenile/normo-
tensive SHR before hypertension had developed
suggesting that these structural changes were not sec-
ondary to the high blood pressure.10 Recently, we
showed that the brainstem of the SHR is hypoper-
fused and becomes severely hypoxic when blood pres-
sure was equated to normotensive levels11 suggesting a
highly limited blood ﬂow reserve in this rat model. We
also found that increasing vertebral artery resistance
increased sympathetic activity (SNA).10,12,13 It is of
interest that SNA is increased in the pre-hypertensive
SHR5,14 but whether this is due to the remodelled
vertebrobasilar arteries and a hypoperfused brainstem
is not clear.
These ﬁndings led to our originally stated selﬁsh
brain hypothesis of hypertension where the brainstem
of an SHR elevates SNA triggering high blood pres-
sure in response to decreased perfusion (caused by the
remodelling of the posterior cerebral arteries) and to
provide adequate brain blood ﬂow.12 This response is
not unlike the Cushing response – increased intracra-
nial pressure results in high cerebral vascular resist-
ance and diminished perfusion, which activates the
sympathetic nervous system to raise systemic blood
pressure.15 However, the mechanisms for this verteb-
robasilar artery remodelling remain elusive but may be
highly relevant to the aetiology of human hyperten-
sion,16 and contribute to the susceptibility of ischemic
stroke occurrence. This was upheld by the association
between hypertension and posterior (but not anterior)
cerebral artery infarcts.13 Thus, we set out to compre-
hensively describe the transcriptomic changes in the
cerebral arteries of the SHR versus the WKY rat.
This led us to build a plausible gene network that
may provide clues to the mechanisms causing the
remodelling both prior to, and during development
of, hypertension. Finally, we performed proof of con-
cept studies to functionally validate outputs from the
gene network.
Materials and methods
Animals
All experiments were conducted in accordance with
the UK Home Oﬃce Scientiﬁc Procedures Act 1986
under project licence PPL 30/3121, and were approved
by the Local Ethical Committees on Animal
Experimentation at the University of Bristol. The
experiments reported here are in compliance with
ARRIVE guidelines on reporting animal experiments.
Animals were sourced from Harlan Laboratories.
In total, 90 male rats were used for this study – 45
WKYs and 45 SHRs. The rats were delivered a
week before their intended use for acclimatisation.
Three age groups were used in this study – 5, 9
and 13 weeks old (Figure 1(A)). In each age group,
animals were pooled into three subgroups of ﬁve,
randomly assigned, animals. Each subgroup would
subsequently serve as a biological replicate for
the RNA sequencing (RNA-Seq) experiment.
The logic of pooling animals was twofold: ﬁrst to
make sure that enough material was collected for
the RNA-Seq platform and, second, as SHRs are
greatly inbred we thought it appropriate that the
‘average’ gene expression from pooling would serve
to give a better overview of the changes to gene
expression. It also provided a satisfactory data quality
to cost ratio.
Tissue collection
Animals were euthanised by an overdose of sodium
pentobarbital (300mg/kg i.p.). Upon loss of the hind
limb withdrawal reﬂex, all animals were perfused
transcardially with 4C PBS (50ml for 5, 80ml for 9
and 120ml for 13-week-old animals) to remove the
blood from the cerebral circulation. Rats were then
transcardially injected with Parker Quink washable
ink to stain the cerebral vessels. The brain was
gently but rapidly removed and the cerebral arteries
(vertebral, basilar posterior communicating and
the circle of Willis) peeled away from the brain
(Figure 1(B)) immersed in cold PBS under a dissecting
microscope. Once isolated, the vessel peel was cleaned
of meninges. The cleaned arteries were snap frozen in
liquid nitrogen and stored at 80C until RNA was
extracted.
Total RNA extraction
Total RNA was extracted using the TriReagent
(Sigma–Aldrich). The protocol was modiﬁed to obtain
maximum precipitation eﬃciency of small RNAs as
described by LC Sciences (www.lcsciences.com).
Brieﬂy, at the RNA precipitation step, 1.5ml of
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isopropyl alcohol was used for each millilitre of
TriReagent. GlycoBlueTM Co-precipitant was added
at 100 mg/ml to visualise the RNA pellet. The samples
were left overnight at 20C to facilitate small RNA
precipitation. After the incubation samples were centri-
fuged at 12,000 g for 10min. Pellets were washed twice
with 75% ethanol and pelleted again at 12,000 g. After
air-drying the pellets for 10min, they were solubilised in
nuclease-free water. The RNA was then cleaned on
Qiagen RNeasy Mini Kit for large (>200 nucleotides)
RNA sequencing.
Total RNA quality control
The quality of extracted RNA was checked on
Nanodrop 1000 and Agilent 2200 TapeStation. All sam-
ples had a 260/280 ratio over 1.8. The RNA integrity
number (RIN) of the total RNA was between 7.7 and
8.5. After column clean-up and removal of the small
RNAs, the RIN of all samples was between 8.1 and 9.3.
RNA sequencing
Approximately 250 ng of total RNA was prepared for
sequencing using the rRNA depletion – Illumina
Truseq stranded RNA LT kit RiboZero. The ﬁnal aver-
age library size distribution was approximately 347
base pairs. Each library was spliced to a unique adap-
ter, and they were equimolarly distributed over four
lanes of an Illumina ﬂow cell. A 100 base pairs
paired-end run was performed through Genomics
Facility at the University of Bristol on an Illumina
HiSeq 2500 platform. The data were processed using
RTA version 1.18.61 with default ﬁlter and quality set-
tings. The reads were demultiplexed with CASAVA
1.8.2 (allowing no mismatch).
Figure 1. Methodology for cerebral artery transcriptomic analysis in normotensive (WKY) and spontaneously hypertensive rats
(SHR) strains. (A) Summary of the animal assignment for tissue extraction. (B) Representative examples illustrating how the cerebral
vessels were collected for RNA and protein extraction. (i) A 25-gauge needle was used to detach the meninges from the brain. (ii) The
tissue was peeled off with watch maker forceps in the rostral direction. (iii) Collected tissue showing the meninges attached to the
vessels. (iv) After stripping most of the meninges off the arteries. (C) Gross visualisation of gene transcription shifts, clustered
hierarchically to WKY changes in gene expression. Each column represents a different age of either WKY rat or SHR. Each row
represents the relative level of expression of a single gene. Red, high expression relative to the mean expression; blue, low expressions
relative to the mean expression; white, no significant change in expression level between the sample and mean. The heat maps
represent a relative longitudinal downregulation (left heat map) and upregulation (right heat map) of transcribed genes in 5 week
compared to 9-week-old WKY rats. Hierarchical clustering in GENE-E grouped genes followed the same pattern of expression in
aging WKY. These genes were then compared to the expression pattern in the SHR at comparable ages. The broad clusters represent
similar expression patterns and are divided by the dashed lines. Compared to the development of normotensive WKY there are clear
transcriptional shifts in the development of the SHR. a-c clusters of low gene expression in pre-hypertensive age. d-e clusters of high
gene expression in pre-hypertensive age. CW: circle of Willis arteries; BA: basilar artery; VA, vertebral arteries.
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RNA-Seq data processing
Raw data were analysed in part via public Galaxy servers
(www.usegalaxy.org).17,18 Data sets were concatenated
head to tail and processed using Trimmomatic v0.32.19
They were converted to Sanger format using FASTQ
Groomer.20 Reads were then aligned to University of
California, Santa Cruz (USCS) rn5 rat genome using
TopHat v2.0.921 default settings with the following
exceptions: the maximum edit distance was set to four
base pairs and four ﬁnal mismatches were allowed.
Coverage search and microexon search were also
allowed. TopHat output was then assembled using
Cuﬄinks v2.2.122,23 with default settings and enabled
bias correction to USCS rn5 genome. Data were then
fed to Cuﬀquant and Cuﬀdiﬀ22,23 quantitation pipeline
with default setting with active multi-read-correction and
bias correction options, and using the per-condition dis-
persion estimation method.
RNA-Seq data analysis
Data processing was performed in R24 v3.2.0 using
CummeRbund package v2.7.2, Qiagen Ingenuity
Pathway Analysis (IPA – release June 2015) and
Panther database.25 Gene heat-maps were created
using GENE-E version 3.0.204.26 Benjamini–
Hochberg (BH) corrected p values less than 0.05 were
considered statistically signiﬁcant. Additionally, genes
had to show (at least) in one condition (WKY or SHR)
an FPKM value of equal or greater than 1. Changes in
genes where both conditions had FPKM< 1 were con-
sidered to be noise related and discarded from this ana-
lysis despite being statistically signiﬁcant.
Histology, image acquisition and analysis
Brain tissue was collected by decapitation and ﬁxed in
4% PFA as previously described.10 After paraﬃn
embedding, sections were cut on a microtome and
stained with either picrosirius red (10mm thick) or
orcein (5mm thick) according to standard protocols.27
Picrosirius red stained vessels were imaged on a
Leica SP5 confocal microscope with a 40 /0.7 oil/gly-
cerol immersion lens as previously described.28 The Z
stack was then maximally projected in Fiji and digital
masks were applied to tunica externa and media using a
semi-automatic macro. The image was then processed
as described in online supplemental methods and ﬂuor-
escence and area of the masks measured.
Second-harmonic generation (SHG) microscopy was
performed on an upright SP8 microscope (Leica
Microsystems) equipped with a DeepSee Ti:Sapphire
multiphoton laser (Spectra Physics) to analyse changes
in collagens. Unstained sections measuring 10 mm were
imaged. The multiphoton laser was tuned to 880 nm to
produce an SHG signal from collagen within the tissue
samples. The signal was captured in the forward
(mature collagen ﬁbres) and backward (immature col-
lagen ﬁbres) direction simultaneously onto non-
descanned PMTs through matched 440/20 nm emission
ﬁlters. Prior to acquisition, the condenser was aligned
following standard Ko¨hler illumination and laser
powers, and detector gains remained constant through-
out the duration of the study.
For ﬂuorescence and SHG microscopy, the images
were processed as described in the online supplemental
methods and ﬂuorescence and area of the region of
interests measured.
The orcein stained sections of basilar arteries were
imaged on an upright Leica DM LB2 with a Colour
Leica DCF 450C camera and 63 dry lens. The elastin
content was assessed by measurement of internal elastic
lamina (IEL) area using the magic wand function
in Fiji.
Statistical analysis
Statistical analysis was performed in GraphPad Prism
version 6.05. Histological samples were blinded to the
experimenter prior data analysis. Provided the require-
ments were satisﬁed, an unpaired Student’s t-test was
used for measurements of histological data. Otherwise,
a non-parametric Mann–Whitney test was used. The
eﬀect size was estimated using Cohen’s d index value
and correlation by r index. We considered p values less
than 0.05 as statistically signiﬁcant.
Results
Gene transcription shift in the SHR cerebral arteries
Gross visualisation of changes in gene transcription
was achieved by hierarchical clustering. Longitudinal
gene changes of WKY rats were compared to SHR.
The transcriptomic changes between WKY rats at 5
and 9 weeks old were examined (genes that FDR cor-
rected p value was <0.05). These genes were then extra-
polated longitudinally to 13-week-old WKY rats and
changes were compared in the SHR. Unchanged
genes were not considered in this analysis.
As WKY rats aged, there were two groups of gene
changes – those that were either up- or down-regulated
in aged 9-/13-week-old WKY rats compared to 5-week-
old counterparts (Figure 1(C)).
Upregulated genes. Three diﬀerent broad clusters
emerged from the upregulated genes (Figure 1(C, a to
c)). The ﬁrst cluster (Figure 1(C, a)) showed 85 genes
that were silent in 5 relative to 9-week-old WKY rats
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and become silenced again at 13 weeks old. In contrast,
in the SHR these genes were relatively silent in 5- and
9-week-old animals and became relatively over-
transcribed at 13 weeks of age.
The second cluster (Figure 1(C, b)) contained 55
genes. They were downregulated in the 5-week-old
WKY rats and became progressively upregulated in 9-
and 13-week-old WKY rats. The SHR followed the
same pattern of expression.
The third cluster (86 genes) showed genes that were
downregulated in 5- and 9-week-old WKY rats but
became strongly transcribed at 13 weeks. In the SHR,
these genes did not show a consistent pattern: some
remained relatively downregulated at all ages while
others were over-transcribed but not to the same
extent as age-matched WKY rats.
Downregulated genes. For downregulated longitudinal
mRNA changes only two large clusters were identiﬁed
(Figure 1(C, d and e)). One cluster (Figure 1(C, d) –
containing 92 genes) showed a high level of downregu-
lation at 9 weeks and a moderate upregulation at 13
weeks of age in WKY rats. In the SHR, these genes
were progressively downregulated at both 9 and 13
weeks of age.
The second cluster ((Figure 1(C, e))) containing 196
genes showed progressive downregulation in the WKY
rat. A similar pattern of expression was also evident in
the SHR.
Of all diﬀerentially transcribed genes, only a few
genes showed constitutive, >twofold change across all
ages analysed (Figure 2(a)). Of these, 32 genes were
constitutively over-transcribed and 23 constitutively
under-transcribed in the SHR (Figure 2(b)). There
were also several collagen types that were changed
(Figure 2(c)).
Classifying gene changes. All the diﬀerentially expressed
genes were assigned to one of 28 protein classes
using the Panther database (online Supplementary
Figure S1). The most under- or over-transcribed
class of genes were receptors with 80, 102 and 112
diﬀerentially expressed genes for 5-, 9- and 13-week-
old animals, respectively. The receptor type changed
the most was G-protein coupled receptors (16.5%,
17.7% and 20% of the total number of receptor
genes for 5-, 9- and 13-week-old animals, respectively).
The next category was hydrolases followed by enzyme
modulators, nucleic acid binding proteins and
transporters.
Based on the molecular function of these genes
(online Supplementary Figure S1) the highest number
of diﬀerentially expressed genes were enzymes (148, 242
and 260 genes for 5-, 9- and 13-week-old animals,
respectively) followed by genes that show binding
activity (145, 239 and 247 genes for 5-, 9- and 13-
week-old animals, respectively) and receptor activity
(78, 100 and 107 genes for 5-, 9- and 13-week-old ani-
mals, respectively).
IPA software identiﬁed a number of processes that
these diﬀerentially expressed genes may be involved in.
Based on gene set enrichment, this analysis assigns gene
sets to predeﬁned networks but no directionality is
assigned, that is it cannot be stated whether these are
up- or downregulated.29
There were 20, 69 and 18 processes (for 5-, 9- and 13-
week-old animals B-H p value< 0.05, respectively) that
these diﬀerentially expressed genes may be involved in
(online Supplementary Figure S2). Of these, 15 pro-
cesses were common in all three age groups (online
Supplementary Table S1).
There were 16, 10 and 17 pathways that were
enriched statistically (B-H p value< 0.05) in the 5-,
9- and 13-week-old SHR, respectively (Figure 3,
online Supplementary Table S1). Only two were high-
lighted at all three ages – hepatic ﬁbrosis (p¼ 0.001,
p¼ 0.004 and p¼ 0.000003 for 5-, 9- and 13-week-old
rats, respectively) and an antigen presentation path-
way (p¼ 0.03, p¼ 0.004 and p¼ 0.007 for 5-, 9- and
13-week-old animals, respectively). Of the pathways
involved in maturation of the blood vessels in
hypertension, six were speciﬁc to pre-hypertensive,
5-week-old SHR. During the development of hyper-
tension (9-week-old SHR) only one pathway was spe-
ciﬁc to that stage (GADD45 pathway) while 12
pathways were speciﬁc to 13-week-old SHR, a time
when hypertension is established. In general, the path-
ways aﬀected most in the pre-hypertensive stage were
heavily involved in immune system modulation (e.g.
Graft-vs-Host signalling, OX40 signalling, athero-
sclerosis signalling, dendritic cell maturation, auto-
immune thyroid disease signalling and antigen
presentation pathways, online Supplementary Tables
S2 and S3) as well as lipid and cholesterol metabolism
(FXR/RXR activation and LXR/RXR activation).
Processes involved in mitochondrial dysfunction and
ATP production (oxidative phosphorylation) were
also evident.
At the development of hypertension, two add-
itional pathways were aﬀected – GADD45 signalling
and axon guidance signalling but Graft-vs-Host dis-
ease signalling, OX40 signalling and dendritic cell
maturation signalling, remained unchanged (p¼ 0.1,
p¼ 0.06 and p¼ 0.2, respectively). After hypertension
was established the gene changes were statistically
linked to additional pathways including tight junc-
tion signalling, integrin signalling, epithelial adhe-
rens junction signalling and cellular eﬀects of
Sildenaﬁl suggestive of change in blood–brain barrier
function.
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Putative upstream activation of differential
gene expression
We analysed putative upstream regulators driving dif-
ferential transcriptomic changes. The regulator itself
does not have to change but drives phenotypic
changes.30 The inhibition and activation score of
these molecules is calculated in IPA. Inhibition/activa-
tion Z-score <2 or >2 is considered highly inhibited or
activated, respectively. The top 10 activated and inhib-
ited regulatory molecules for each age were analysed
and presented in Figure 4(a). As in the canonical path-
way analysis (see above), there was a progressive
Figure 2. Representation of genes that showed log2(fold change) 1 and log2(fold change) 1 at various stages of hypertension
development in SHR. Genes were divided into over- and under-expressed relative to WKY rats for the three ages studied (5, 9 and 13
weeks old). (a) The Venn diagrams show the number of genes unique and common to various ages and those that are constitutively
changed at all ages. The sizes of the circles are proportional to total number of genes. (b) Genes constitutively upregulated and
downregulated, at all analysed time points in the SHR as compared to WKY rat with log2(fold change) 1 and log2(fold change) 1.
(c) Various collagens that showed differential expression in the SHR as compared to WKY. Agr2: anterior gradient protein 2 homolog;
Aldh1a1: aldehyde dehydrogenase 1 family, member A1; ApoD: apolipoprotein D; Bdkrb2: Bradykinin receptor B2; Chi3l1: Chitinase-
3-like protein 1; Cldn2: Claudin-2; Clec2l: C-type lectin domain family 2 member L; Col9a1: collagen type IX alpha 1 chain; Cox5a:
cytochrome c oxidase subunit 5A, Creg1: cellular repressor of E1A stimulated genes 1; Eno1: Enolase-1; Ephx2: epoxide hydrolase-2;
Figf: C-fos-induced growth factor; Fkbp9: FK506 binding protein 9, Frzb: frizzled-related protein; Gpm6a: Glycoprotein M6A; Il33,
interleukin-33; Kcnj15, potassium inwardly-rectifying channel, subfamily J, member 15; Kcns3, potassium voltage-gated channel
modifier subfamily S member 3; Klrk1, killer cell lectin like receptor K1; Lig4: DNA Ligase 4; Lilrb3l, leukocyte immunoglobulin-like
receptor, subfamily B, member 3-like; Lpl, lipoprotein lipase; Lrrtm4, leucine rich repeat transmembrane neuronal 4; Mettl2b,
methyltransferase like 2B; Mycbpap, MYCBP associated protein; Ngfr, nerve growth factor receptor; Nt5c3a: cytosolic 50-nucleotidase
3; Pkhd1l1: polycystic kidney and hepatic disease-like 1; RGD1311723: centrosomal protein 295; RGD1312005: similar to DD1;
RGD1560672: coiled-coil domain containing 190; RT1-A1: RT1 class Ia, locus A1; RT1-Ba: RT1 class II, locus Ba; RT1-CE15: RT1 class I,
locus CE15; RT1-N2/RT1-N3: RT1 class Ib, locus N2/RT1 class Ib, locus N3; Rtel1: regulator of telomere elongation helicase 1; Sec16b:
Sec16 homolog B, Serpina1: Alpha-1-antitrypsin; Slc11a1: natural resistance-associated macrophage protein 1; Slc5a11: sodium/myo-
inositol cotransporter 2; Srxn1: sulfiredoxin 1; St6galnac2: sialyltransferase 7B; Stard6: StAR-related lipid transfer protein 6; Sumo2:
small ubiquitin-related modifier 2; Thsd7b: thrombospondin type 1 domain containing 7B; Trim6: tripartite motif containing 6; Ube3d:
ubiquitin protein ligase E3D.
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phenotypic shift from the pre-hypertensive, through to
the onset and into the established hypertensive phase.
Activated regulators. At the pre-hypertensive age, the vas-
cular transcriptomic gene changes were predicted to be
caused by pro-ﬁbrotic regulators (e.g. transforming
growth factor beta 1 – TGFB1, p¼ 4 1017, signal
transducer and activator of transcription 3 – STAT3,
p¼ 7.8 105, hypoxia inducible factor 1 alpha –
HIF1A, p¼ 1.35 104) and regulators involved in
immune system modulation (e.g. atypical chemokine
receptor 2 – ACKR2, p¼ 8.13 105, nuclear receptor
subfamily 1, group H, member 2 – NR1H2,
p¼ 8.13 105, STAT3).
At the onset of hypertension, a combination of
growth factors (e.g. insulin-like growth factor 1 –
IGF1, basic ﬁbroblast growth factor – FGF2, vascular
endothelial growth factor A – VEGFA, somatotropin –
GH1) and nuclear factor receptor kappa (NF-kB)
signalling modulation was inferred (e.g. inhibitor of
nuclear factor kappa-B kinase subunit beta and
gamma – IKBKB and IKBKG, nuclear factor NF-
kappa-B inhibitor kinase alpha – CHUK).
In the established hypertension phase, a partial
reversal to the pre-hypertensive pro-ﬁbrotic and
immune modulation dysfunction was inferred.
Additionally, the transcriptomic changes in this phase
of hypertension appear to be driven by sex hormone-
related signalling axis (e.g. oestrogen receptor alpha –
ESR1, androgen receptor – AR). An example of the
interplay between activated regulators is shown in
Figure 4(b).
Figure 3. Global canonical pathways that may play a role in cerebrovascular remodelling in the SHR at various stages of hypertension
development. The pathways were derived from transcriptomic changes between age-matched SHR and WKY rats and sorted
according to the likelihood of involvement in the SHR cerebral artery phenotype such as immune system in the pre-hypertensive SHR.
At the onset of the hypertension the stress signalling genes (e.g. GADD45) is upregulated and only after hypertension is established
does endothelial dysfunction occur. This indicates that vascular remodelling at the pre-hypertensive stage is different to that during
established hypertension. The onset of hypertension triggers an intermediate phenotype, presumably as a response to the increasing
blood pressure. The p values are corrected for false discovery rate (Benjamini–Hochberg correction). The stacked bar columns
represent the percentage of genes involved in a particular signalling pathway and their expression level compared to age-matched
control rats (WKY). Hep Fib/ HSC Activ: hepatic fibrosis / hepatic stellate cell activation; FXR/RXR Activ: FXR/RXR activation; GvH:
Graft-versus-Host disease; LXR/RXR Activ: LXR/RXR activation, OX40 Sign Path: OX40 signalling pathway; Oxid Phospho: oxidative
phosphorylation; AS: atherosclerosis signalling; DC Maturation: dendritic cell maturation; ATD Signalling: autoimmune thyroid disease
signalling; Mito Dys: mitochondrial dysfunction, EIF2 Sign: EIF2 signalling; CR sign: circadian rhythm signalling; AP Pathway: antigen
presentation pathway, Axon Guid Sign: axonal guidance signalling; GADD45 Sign: GADD45 signalling; TJ Sign: tight junction signalling;
ILK: integrin linked kinase; CmE: clathrin-mediated endocytosis signalling; T1D sign: type I diabetes mellitus signalling; AG Sign: axonal
guidance signalling; Ca2þ Transp: calcium transport; EAJ: epithelial adherens junction; Ca2þ Sign: calcium signalling; Cell Eff of Sid:
cellular effects of sildenafil; 3-P Deg: 3-phosphoinositide degradation; Actin CS Sign: actin cytoskeleton signalling.
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Inhibited regulators. At the pre-hypertensive age, the
transcriptomic changes were largely driven by inhib-
ition of toll-like receptor 3 (TLR3) signalling axis
(interferon regulatory factor 3 – IRF3) and type I inter-
feron signalling axis (e.g. interferon alpha 1 and beta
1 – IFNA1 and IFNB1, interferon regulatory factor
Figure 4. Changes in predicted upstream regulators of transcriptomic changes in the cerebral arteries of the SHR. (a) The top 10
activated and inhibited regulators across all ages of analysed samples that may potentially be involved in the age-related transcriptomic
changes in the cerebral vasculature in the SHR are shown. The interplay of (b) activation of pro-fibrotic and (c) inhibition of
vasoprotective regulators are also shown as inferred by IPA analysis. Pro-fibrotic regulators are inferred to be activated whereas the
vasoprotective regulators are inhibited early in the pre-hypertensive SHR. The activation of pro-fibrotic regulators persists throughout
all analysed time points. Additionally, at the onset (9 weeks) of hypertension, there is inhibition of miRNAs that are thought to be anti-
proliferative and anti-migratory, suggestive of increased proliferation, likely of vascular smooth muscle cells – hallmark of vascular
remodelling in hypertension. p-Values are reported as exact Fischer values. The relationship edges are coloured orange if they lead to
activation and blue if they lead to inhibition of a downstream node. The edge is yellow when the relationship cannot be explained by
the state of differential gene transcription. ACKR2: atypical chemokine receptor 2; AGT: angiotensiongen; AR: androgen receptor;
CEBPB: CCAAT/enhancer-binding protein beta; CHUK: conserved helix-loop-helix ubiquitous kinase; CR1L: complement component
receptor 1-like protein; EGFR: epidermal growth factor receptor; ESR1: oestrogen receptor; FGF2: fibroblast growth factor 2; GH1:
somatotropin; GNA13: guanine nucleotide-binding protein subunit alpha-13; HIF1A: hypoxia-inducible factor 1-alpha; HMGA1: high
mobility group protein HMG-I/HMG-Y; IGF1: insulin-like growth factor 1; IGFR1: insulin-like growth factor 1 receptor; IKBKB:
inhibitor of nuclear factor kappa-B kinase subunit beta; IKBKG: NF-kappa-B essential modulator; IL6: interleukin-6; INFA1: interferon
alpha-1; INFA2: interferon alpha-2; INFAR1: interferon-a/b receptor; INFB1: interferon beta-1; INFG: interferon gamma; IRF3:
interferon regulatory factor 3; IRF7: interferon regulatory factor 7; MAPK1: mitogen-activated protein kinase 1; MAPK11: mitogen-
activated protein kinase 11; MYCN: N-myc proto-oncogene protein; NFKBIA: NF-kappa-B inhibitor alpha; NKX2-3: NK2 tran-
scription factor related, locus 3; NR1H2: oxysterols receptor LXR-beta; PARP9: poly [ADP-ribose] polymerase 9; PML: promyelocytic
leukaemia protein; PPARG: peroxisome proliferator-activated receptor gamma; PTGER4: prostaglandin E2 receptor EP4 subtype;
RELA: REL-associated protein; RICTOR: Rapamycin insensitive companion of mTOR; RUNX2: Runt-related transcription factor 2;
SP1: transcription factor Sp1; STAT1: signal transducer and activator of transcription 1; STAT3: signal transducer and activator of
transcription 3; TBX5: T-box transcription factor 5; TGFB1: transforming growth factor beta-1; TGFB3: transforming growth factor
beta-1; TGM2: glutamine-gamma glutamyltransferase 2; TLR3: toll-like receptor 3; TNF: tumour necrosis factor; TP53: tumour protein
p53; TRIM24: tripartite motif-containing 24; VEGFA: vascular endothelial growth factor A.
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7 – IRF7, signal transducer and activator of tran-
scription 1 – STAT1). The possible role of
Rapamycin-insensitive companion of mTOR
(RICTOR) in this signalling axis is highlighted in
Figure 4(c). Additionally, dysregulation of complement
was inferred by inhibition of complement component
3b/4b receptor 1-like (CR1L).
At the onset of hypertension several microRNAs
appeared to have been inhibited (e.g. miR29b-3p,
miR744-5p). The inhibition of RICTOR and IRF7 sig-
nalling persisted through this stage of hypertension
development.
After hypertension becomes established the inhib-
ition of signalling axes from the pre-hypertensive
stage becomes apparent once more (e.g. inhibition of
IFNA1/IFNB1-IRF7-STAT1).
Fibrosis points towards changes in extracellular
matrix deposition in pre-hypertensive rats; proof
of concept
The ﬁbrosis pathway was a common denominator of
the progression of the remodelling as the SHR ages
(Figure 3). Based on this, we hypothesised that
Figure 5. Comparison of the fibrillar collagen content in basilar arteries in 5-week-old SHR and WKY. (a) Representative images of
the basilar arteries. Inset boxes indicate high power images of a section through the artery wall. (b) Tunica externa had the same area
in both strains, but the area of tunica media was larger in the SHR. The total collagen (type I and III) fluorescence was lower in both
tunica externa and media in the SHR relative to WKY rats. Collagen fluorescence to area ratio was reduced in the SHR compared to
WKY rat in both tunica externa and media. (c) Representative images of basilar arteries. (d) Forward to backward (F:B) scatter ratios
of tunica externa and media. The decreased F:B ratio in tunica externa of SHR suggests an increased level of fibrillogenesis of collagen
type I. This in conjunction with decreased total levels of fibrillar collagen suggests an increase of collagen type I to type III ratio. (e)
Representative images of basilar arteries stained with orcein to visualise internal elastic lamina (IEL). (f) The IEL area was greater in the
pre-hypertensive SHR as compared to age-matched WKY rat. The IEL:wall area remained constant, and there was a shift in collagen
type I to collagen III ratio. Scale bar¼ 50 mm. Values are mean SD. *p< 0.05, **p< 0.01, ***p< 0.001. E: tunica externa; M: tunica
media.
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activated ﬁbrotic pathways increased collagen content
in the basilar arteries in the pre-hypertensive stage, con-
tributing to their stiﬀness and reduced compliance.
However, contrary to our hypothesis, combined colla-
gen I and III content (visualised by picrosirius red
ﬂuorescence) was diminished in pre-hypertensive basi-
lar arteries of the SHR (Figure 5(a) and (b)). The col-
lagen ﬂuorescence of tunica externa of the 5-week-old
SHR was 19% lower than that of age-matched WKY
rats (157.6 20.2 vs. 193.7 12.0 AU (arbitrary units),
respectively, p< 0.01, d¼ 2.17, r¼ 0.74). Tunica media
also showed lower ﬂuorescence intensity of collagens I
and III in the SHR as compared to age-matched WKY
rat (23% reduction, 110.1 15.0 vs. 142.9 8.8 AU,
p< 0.001, d¼ 2.67, r¼ 0.80). Comparatively the ratio
of ﬂuorescence to the area of tunica externa and
media were lower in the SHR (p< 0.01 and p< 0.001,
respectively). However, consistent with our hypothesis,
mRNA levels of several other collagen types subunits
(e.g. col4a1, col9a1) were all increased in SHRs relative
to age-matched WKY (Figure 2(c)).
As picrosirius red stains all ﬁbrillar collagen (in ves-
sels mainly collagen type I and III) it was not clear
which type was diminished in the pre-hypertensive
SHR. To further explore this, we performed second
harmonics generation (SHG) microscopy on these ves-
sels. The SHG provides information based on light
scattering that passes through the structures (in vessels
collagen type I). Light scattered in the forward direc-
tion reﬂected mature collagen ﬁbrils whereas in the
backward direction immature collagen ﬁbrils.
Therefore, by comparing the forward to backward scat-
ter (F:B ratio) we compared relative collagen type I
synthesis between conditions and deduced the ﬁbrillo-
genesis state.
There was an increase in the forward scatter signal in
both tunica externa and media of the basilar arteries in
pre-hypertensive SHR (19.19 5.54 vs. 11.06 3.42 AU,
p< 0.05, d¼ 1.77, r¼ 0.66 and 5.33 0.73 vs.
3.82 0.36 AU, p< 0.01, d¼ 2.62, r¼ 0.80, respectively)
as compared to age-matched WKY rat (Figure 5(c),
Table 1). The backward scatter signal was also increased
in the basilar arteries of pre-hypertensive SHR when
compared to age-matched WKY rats (25.19 8.55 vs.
87.01 42.80 AU, p< 0.05, d¼ 2.00, r¼ 0.71).
Intriguingly, the F:B ratio in the tunica externa was
lowered in the pre-hypertensive SHR as compared to
age-matched WKY rat (Figure 5(d) and Table 1,
0.26 0.13 vs. 0.43 0.03, p< 0.05, d¼ 1.75, 0.66) but
not in the tunica media (0.29 0.08 vs. 0.30 0.03,
p¼ 0.76, d¼ 0.20, r¼ 0.10). This suggests increased col-
lagen type I synthesis/turnover in the adventitia of the
basilar arteries of the SHR.
The IEL – containing elastic ﬁbres had a greater area
in the 5-week-old SHR than in an aged matched WKY
(2692 565 vs. 2076 142 mm2, p< 0.05, d¼ 1.50,
r¼ 0.60, Figure 5(e) and (f)). This was consistent with
upregulation of elastin and ﬁbrillin 2 transcripts at pre-
hypertensive stage (online Supplementary Figure S4).
The ratio of IEL to media area, however, remained
constant.
Discussion
This study was conducted to identify global gene
expression changes in the main posterior cerebral
arteries prior to, and during, the development of hyper-
tension in the SHR. The transcriptomic changes were
most consistently linked to the ﬁbrosis and immune
system regulatory pathways. These in turn might have
been driven by pro-ﬁbrotic (e.g. TGFb), anti-apoptotic
(e.g. IGF1) and pro-migratory (e.g. FGF2) molecules
as they were all activated in the pre-hypertensive SHR.
Immune modulation signalling (e.g. interferons, TLR3
and STAT1 signalling) all appeared to be inhibited at
all ages in the SHR compared to the WKY rat. A sur-
prising ﬁnding was the plasticity of the transcriptomic
changes. It appeared that the remodelling of the
Table 1. Comparison of forward and backward scatter of 5 weeks old basilar arteries from the SHR and WKY rat.
WKY (n¼ 5) SHR (n¼ 7) p Value Cohen’s d
Tunica externa forward (F) scatter (AU) 11.06 3.42 19.19 5.54 0.024 1.76
Tunica media forward scatter (AU) 3.82 0.36 5.33 0.73 0.003 2.62
Tunica externa backward (B) scatter (AU) 25.19 8.55 87.01 42.80 0.012 2.00
Tunica media backward scatter (AU) 12.87 2.43 19.80 6.19 0.055 1.47
Tunica externa, F:B ratio 0.43 0.03 0.26 0.13 0.02 1.83
Tunica media, F:B ratio 0.30 0.03 0.29 0.08 0.76 0.20
Note. Second-harmonic generation microscopy was performed to assess collagen type I content within sections of basilar artery. The signal was
captured in the forward and backward direction simultaneously. The increase in forward scatter signal of both tunica externa and media of the SHR
basilar artery suggest an increase of fibrillar collagen type I. The increase of backward scatter in the tunica externa in the basilar artery of the SHR
suggests increased fibrillogenesis indicating higher synthesis turnover of collagen type I. Values are mean SD.
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cerebral arteries in the pre-hypertensive SHR is diﬀer-
ent phenotypically to both the onset and developed
hypertension phases of this rat model. For example,
endothelial dysfunction was not apparent until hyper-
tension had developed as shown by the enrichment of
endothelial-speciﬁc pathways (e.g. tight junction signal-
ling). Moreover, relatively few genes were persistently
over- and under-transcribed at all analysed time points.
Below we discuss how the alterations in transcriptomic
expression may contribute to the changes in collagen
content and stiﬀening of the cerebral vessels in the
SHR, which support our selﬁsh brain hypothesis of
hypertension.
Limitations
Several limitations must be acknowledged in the cur-
rent study. It was performed on whole vessels without
discrimination to the respective cell types within the
vessel itself. Therefore, some pathways cannot be
assigned to speciﬁc cell type, for example proliferation
can refer to immune system cells, smooth muscle, ﬁbro-
blasts and/or endothelium. The database exploration
and modelling are based on current knowledge and
available literature, and so many uncharacterised
genes have been omitted from our analysis.
Mechanisms of arterial stiffening in the SHR
As visualised by picrosirius red staining, total collagen
was decreased in the basilar arteries of 5-week-old
SHRs. Total ﬁbrillar collagen (type I and III) was
reduced by approximately 20% in the basilar arteries
of the pre-hypertensive SHR compared to age-matched
WKY rats. However, this method highlights ﬁbrillar
collagen only,31 which is primarily composed of colla-
gen I, III, V in arteries32 but other types of ﬁbrillar
collagen exist.33 Although counterintuitive, a decrease
in the level of ﬁbrillar collagen in vascular remodelling
is well documented. It has been proposed that the
change in the ratio of collagen I and III to other
types of collagen is the cause of increased arterial stiﬀ-
ness34,35 and as found herein. The decrease of ﬁbrillar
collagen we found was reported previously in 6-week-
old SHRs.35
For the ﬁrst time, we show that there is an increase
in type I collagen in the basilar arteries of pre-hyper-
tensive SHRs relative to WKY rats with discrimination
to speciﬁc substructures of the blood vessels (i.e. tunica
externa and media). This increased level of type I col-
lagen may contribute to increased stiﬀness as it does in
the heart.36 In the present study, SHG microscopy
revealed that there was an increase in collagen I
signal in both tunica externa and media in pre-
hypertensive SHR. Additionally, there was a shift in
forward to backward scatter (F:B) ratio of SHG
signal in the tunica externa of the pre-hypertensive
SHR basilar arteries suggestive of increased ﬁbrillogen-
esis.37 Taken together, there was a shift in the collagen
type I to III ratio in favour of collagen I. As collagen I
provide rigidity and collagen III elasticity, the vessel
with such a ratio shift will have reduced compliance,
and this may contribute to the raised vascular resist-
ance we have reported previously.38 We also note that
there was an increase of collagen IV subunit
(COL4A1). It does not escape us that mutations of
this subunit may result in vascular abnormalities – in
particular fragility of cerebral vessels.39,40 It follows
then that increased expression of this subunit may con-
versely result in increased vessel stiﬀness – this notion,
however, needs to be conﬁrmed further experimentally.
The vessel stiﬀening would have likely resulted in an
increase of pulse pressure which was documented
previously.41,42
An opinion regarding the involvement of the
immune system in the generation of ﬁbrotic tissue is
that an inﬂammatory response occurs after vascular
injury and therefore must be a secondary mechanism
rather than being causal.43 However, our results show
that an early immune response in the pre-hypertensive
SHR occurs before the onset of hypertension and is
prevailing (together with ﬁbrosis) throughout all ages.
Interestingly, one gene we identiﬁed as upregulated was
alpha enolase (Eno1, Figure 2(b)) that has been linked
to autoimmune disorders such as Hashimto’s encephal-
opathy44 and asthma.45 A symptom of one of them –
Behcet disease, is a form of vasculitis. It is thought that
surface alpha enolase acts as an autoantigen for endo-
thelial damage.46 Given its constitutive upregulation
alpha enolase may play a role in the long-term endo-
thelial damage and immune system disorders in the
SHR brainstem. Waki et al. showed an increase in
adhesion of leukocytes within the brainstem microvas-
culature of the pre-hypertensive SHR, perhaps driving
inﬂammation.47,48 Antagonism of inﬂammation has
been successful in lowering of blood pressure in the
adult SHR.49
The presence of immune cells in cerebral vascula-
ture has been observed before.48,50,51 The early
involvement of immune system pathways is suggestive
of ongoing inﬂammation. This inﬂammation may be
involved in production of ROS and downstream sig-
nalling that can also trigger ﬁbrosis.52–55 Residing
macrophages and circulating monocytes may be the
source of TGFb molecules with the ROS promoting
the excessive scarring proﬁle.56,57 The inhibition of
interferon signalling we found may be causal to, or
agonise an existing, immune response. Interferon
modulates the immune system and has been used for
treatment of autoimmune disorders (e.g. multiple
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sclerosis)58 as well as certain malignancies (e.g. melan-
oma). This remains to be validated in future work.
Interestingly, a genome sequence of the SHR reveals
a gain of a stop codon at amino acid position 168
(G168X) of toll like receptor 3 signalling which
agrees with our model prediction of inhibition of
TLR3 signalling (Figure 4).59
Activation of RXR signalling leads to GADD45 sig-
nalling, which has anti-proliferative properties.60,61
GADD45 signalling was enriched at the onset of the
hypertension (9 weeks) in the SHR as well as an anti-
proliferative and anti-migratory eﬀect of miRNAs:
mir-744-5p, mir-29b-3p, mir-296-5p, mir-149-3p and
mir-4707-3p. Mir-744-5p has anti-proliferative proper-
ties and with their reduction increased cell proliferation
may result.62,63 These results indicate that at the onset
of hypertension there is a switch from anti- to pro-pro-
liferative phenotype as well as increased migration,
likely caused by increasing intraluminal outward pres-
sure on the vessel wall further driving cerebral artery
remodelling.
Conclusions
All told, these ﬁndings suggest that the cerebrovascular
remodelling in a rodent genetic model of hypertension
shows a high degree of plasticity occurring prior to, and
during the development of, hypertension. The initiating
insult to the cerebral arteries is likely caused by the
dysregulated pro-ﬁbrotic and inﬂammatory pathways.
Upon onset of hypertension, there appears to be a
‘phenotypic switch’ (increased proliferation, migration
and later endothelial dysfunction) presumably to
accommodate the increasing intravascular pressure.
We propose a hypothetical model (Figure 6) in
which a dysregulated inﬂammatory response leads to
immune cell inﬁltration of cerebral blood vessels of
the SHR leading to pro-ﬁbrotic signalling that results
in decreased vessel compliance and diminished cerebral
blood ﬂow at physiological blood pressure.10 This may
lead to brainstem hypoperfusion11 that is counteracted
by the Cushing mechanism.15 The increasing outward
pressure on the artery wall leads to a secondary insult
and phenotypic changes, worsening vessel ﬁbrosis and
compounding stiﬀening. The inhibition of anti-prolif-
erative and anti-migratory miRNA eﬀects as well as
activation of growth factor signalling leads to cell pro-
liferation and migration that result in secondary hyper-
trophic remodelling together with an increase in
extracellular matrix turnover. As the hypertension
becomes established the immune system dysfunction
continues and endothelial dysfunction sets in, including
Figure 6. Putative pathway driving cerebrovascular remodelling in the pre-hypertensive SHR. Based on our transcriptomic analysis,
we propose that some neoantigen/autoantigen (e.g. enolase-1, Eno1) drives an inflammatory pathway that leads to immune cells
infiltration of blood vessels, which we have described previously.49,51,65,66 This causes a shift in the extracellular matrix deposition and
vessel stiffening that leads to elevated cerebrovascular resistance and decreased blood flow triggering increased SNA through the
Cushing mechanism. Thus, brainstem hypoperfusion results in activation of the sympathetic nervous system and hypertension. The
increased blood pressure serves as a secondary insult that triggers increased vascular smooth muscle proliferation, migration and
hypertrophy as well as endothelial dysfunction. These processes propagate the development of hypertension further in a positive
feedback loop.
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a break down in blood brain barrier function.64
We predict that targeting of the immune system dys-
function early on in the disease process may provide
an approach to prevent the development of high cere-
bral vascular resistance and subsequent hypertension in
the SHR.
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